196 related articles for article (PubMed ID: 22050235)
1. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
[TBL] [Abstract][Full Text] [Related]
2. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
4. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
[TBL] [Abstract][Full Text] [Related]
5. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and associations of high-mitotic-rate melanoma.
Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
[TBL] [Abstract][Full Text] [Related]
7. Anorectal amelanotic melanoma.
Hillenbrand A; Barth TF; Henne-Bruns D; Formentini A
Colorectal Dis; 2008 Jul; 10(6):612-5. PubMed ID: 17944970
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
9. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.
Li Q; Murphy M; Ross J; Sheehan C; Carlson JA
J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322
[TBL] [Abstract][Full Text] [Related]
10. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
Orlow SJ; Silvers WK; Zhou BK; Mintz B
Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
[TBL] [Abstract][Full Text] [Related]
11. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
Gong HZ; Zheng HY; Li J
Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
16. Amelanotic malignant melanoma: two collision tumors presenting as basal cell carcinoma and atypical fibroxanthoma.
McGregor DH; Cherian R; Romanas MM; Ulusarac O; Mathur SC; Feldman MM
Ann Clin Lab Sci; 2008; 38(2):157-62. PubMed ID: 18469362
[TBL] [Abstract][Full Text] [Related]
17. Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck.
Guo W; Yin G; Liu H; Duan H; Huang Z; Chen X
Acta Otolaryngol; 2020 Sep; 140(9):785-788. PubMed ID: 32449432
[No Abstract] [Full Text] [Related]
18. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
19. Solar elastosis in cutaneous melanoma.
Vollmer RT
Am J Clin Pathol; 2007 Aug; 128(2):260-4. PubMed ID: 17638660
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype.
Jaimes N; Braun RP; Thomas L; Marghoob AA
J Eur Acad Dermatol Venereol; 2012 May; 26(5):591-6. PubMed ID: 21585561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
